相似文献
1
Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.
Mol Ther. 2009 Apr;17(4):585-92. doi: 10.1038/mt.2009.5. Epub 2009 Feb 17.
2
Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.
Hum Gene Ther Methods. 2012 Jun;23(3):157-68. doi: 10.1089/hgtb.2011.209. Epub 2012 Jul 13.
3
Electroporation-enhanced delivery of nucleic acid vaccines.
Expert Rev Vaccines. 2015 Feb;14(2):195-204. doi: 10.1586/14760584.2015.990890. Epub 2014 Dec 9.
4
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?
Drug News Perspect. 2010 Dec;23(10):647-53. doi: 10.1358/dnp.2010.23.10.1513492.
5
Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
J Control Release. 2019 Aug 28;308:14-28. doi: 10.1016/j.jconrel.2019.06.041. Epub 2019 Jun 29.
6
Electroporation delivery of DNA vaccines: prospects for success.
Curr Opin Immunol. 2011 Jun;23(3):421-9. doi: 10.1016/j.coi.2011.03.008. Epub 2011 Apr 27.
7
Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
Hum Vaccin Immunother. 2013 Oct;9(10):2041-8. doi: 10.4161/hv.25272. Epub 2013 Jun 11.
8
Clinical potential of electroporation for gene therapy and DNA vaccine delivery.
Expert Opin Drug Deliv. 2016;13(2):295-310. doi: 10.1517/17425247.2016.1121990. Epub 2015 Dec 19.
9
Electroporation for therapeutic DNA vaccination in patients.
Med Microbiol Immunol. 2015 Feb;204(1):131-5. doi: 10.1007/s00430-014-0384-8. Epub 2014 Dec 23.
10
In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8 T cells.
Vaccine. 2017 Dec 19;35(52):7240-7249. doi: 10.1016/j.vaccine.2017.11.011. Epub 2017 Nov 22.
引用本文的文献
1
Cancer vaccines: current status and future directions.
J Hematol Oncol. 2025 Feb 17;18(1):18. doi: 10.1186/s13045-025-01670-w.
2
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development.
Clin Exp Vaccine Res. 2024 Apr;13(2):73-82. doi: 10.7774/cevr.2024.13.2.73. Epub 2024 Apr 30.
3
Precise genome-editing in human diseases: mechanisms, strategies and applications.
Signal Transduct Target Ther. 2024 Feb 26;9(1):47. doi: 10.1038/s41392-024-01750-2.
4
Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors.
Biomaterials. 2023 Sep;300:122185. doi: 10.1016/j.biomaterials.2023.122185. Epub 2023 May 31.
5
Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma.
Pharmaceutics. 2022 Nov 10;14(11):2429. doi: 10.3390/pharmaceutics14112429.
6
Electroporation-Based Treatments in Urology.
Cancers (Basel). 2020 Aug 7;12(8):2208. doi: 10.3390/cancers12082208.
7
Development of a Simple and Quick Method to Assess Base Editing in Human Cells.
Mol Ther Nucleic Acids. 2020 Jun 5;20:580-588. doi: 10.1016/j.omtn.2020.03.004. Epub 2020 Mar 17.
8
Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials.
Neurobiol Dis. 2020 Jun;139:104823. doi: 10.1016/j.nbd.2020.104823. Epub 2020 Feb 28.
9
A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle.
Int J Mol Sci. 2019 Jun 6;20(11):2776. doi: 10.3390/ijms20112776.
10
Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.
PLoS One. 2019 May 31;14(5):e0217762. doi: 10.1371/journal.pone.0217762. eCollection 2019.
本文引用的文献
1
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
J Clin Oncol. 2008 Dec 20;26(36):5896-903. doi: 10.1200/JCO.2007.15.6794. Epub 2008 Nov 24.
2
What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues.
Mol Biotechnol. 2009 Mar;41(3):286-95. doi: 10.1007/s12033-008-9121-0. Epub 2008 Nov 18.
3
Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration.
Expert Opin Biol Ther. 2008 Nov;8(11):1645-57. doi: 10.1517/14712598.8.11.1645.
4
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13538-43. doi: 10.1073/pnas.0806901105. Epub 2008 Sep 2.
5
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.
Vaccine. 2008 Jul 23;26(31):3947-57. doi: 10.1016/j.vaccine.2007.12.060.
6
Effects of plasmid growth hormone-releasing hormone treatment during heat stress.
DNA Cell Biol. 2008 Nov;27(11):629-35. doi: 10.1089/dna.2008.0758.
7
Growth hormone-releasing hormone plasmid treatment by electroporation decreases offspring mortality over three pregnancies.
Mol Ther. 2008 Nov;16(11):1891-7. doi: 10.1038/mt.2008.178. Epub 2008 Aug 19.
8
Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Vaccine. 2008 Nov 18;26(49):6225-31. doi: 10.1016/j.vaccine.2008.07.052. Epub 2008 Aug 8.
9
Non-viral gene delivery with cationic liposome-DNA complexes.
Methods Mol Biol. 2008;433:159-75. doi: 10.1007/978-1-59745-237-3_10.
Zotero 插件